You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell priming

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Imus, Makati City (PepGNP-COVID19 (One vaccination), Water for injection

Not yet recruiting
  • Coronavirus
  • +2 more
  • PepGNP-COVID19 (One vaccination)
  • +3 more
  • Imus, Cavite, Philippines
  • +1 more
Nov 30, 2022

Diffuse Large B Cell Lymphoma Trial (Bridging Radiotherapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Bridging Radiotherapy
  • Leeds, United Kingdom
  • +2 more
Dec 6, 2022

Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)

Completed
  • Dengue
  • LD vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health, (Unisante)
Nov 28, 2022

Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)

Completed
  • Coronavirus
  • +2 more
  • LD Vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health (Unisante)
Nov 28, 2022

Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

Recruiting
  • Non-Hodgkin Lymphoma
  • Focal radiation therapy (RT)
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 8, 2022

Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

Completed
Has Results
  • Leukemia, Erythroblastic, Acute
  • Myelodysplastic Syndromes
  • New York, New York
    Weill Cornell Medical College
Aug 25, 2021

NSCLC Trial in Amsterdam (Ipilimumab, Cemiplimab, SBRT)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoek - Netherlands Cancer Institute
Jan 10, 2023

NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Immune checkpoint inhibitor
  • Radiation Therapy
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 10, 2022

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • CAR-T Therapy
  • Hefei, Anhui, China
  • +7 more
Jul 31, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023

ASCT Versus Chemotherapy as First-Line Consolidation Therapy

Completed
  • T-cell Lymphoma Adults
  • consolidation with ASCT
  • (no location specified)
Nov 25, 2023

Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma Trial in Xiamen (Chidamide combined

Recruiting
  • Peripheral T Cell Lymphoma
  • +2 more
  • Chidamide combined with Duvillisib
  • Xiamen, Fujian, China
    The First Affiliated Hosptial of Xiamen University
Nov 28, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Not yet recruiting
  • Lymphoma
  • Chimeric Antigen Receptor
  • (no location specified)
Oct 24, 2023

T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

Recruiting
  • T-Cell Acute Lymphocytic Leukemia
  • CD7 CAR-T
  • Langfang, Hebei, China
    Hebei Yanda Hospital
Jun 26, 2023

T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

Not yet recruiting
  • T Cell Lymphoma
  • New Haven, Connecticut
    Yale Smilow Cancer Hospital
Aug 14, 2023

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma Trial in Changchun (Rituximab,

Recruiting
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Angioimmunoblastic T-cell Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 7, 2023

Circulating Tumor DNA Sequencing in Peripheral T-cell Lymphomas

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • circulating tumoral DNA detection
  • Rouen, France
    Centre Henri Becquerel
Oct 13, 2023

Previously Untreated Peripheral T-cell Lymphoma Trial in Tampa, Saint Louis, New York (CC-486 Administration, CHOP

Active, not recruiting
Has Results
  • Previously Untreated Peripheral T-cell Lymphoma
  • CC-486 Administration
  • CHOP Administration
  • Tampa, Florida
  • +3 more
Jan 18, 2023